World News: 21:30 GMT Thursday 8th November 2018. [Intellia Therapeutics, Inc. via Globe Newswire via SPi World News]
CAMBRIDGE Mass Nov 08 2018 GLOBE NEWSWIRE -- Intellia Therapeutics Inc NASDAQNTLA a leading genome editing company focused on developing curative therapeutics using CRISPRCas9 technology both and will participate in the following upcomin...
Globe Newswire: 21:30 GMT Thursday 8th November 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.